Treatments and preparations for canine spinal cord diseases

Abstract

This invention relates to a treatment method for canine spinal cord disease, comprising administering to dogs with spinal cord disease a formulation containing a compound of formula (I) as an active ingredient [where R represents hydrogen or a pharmacologically permissible cation]. This invention also relates to a therapeutic formulation for canine spinal cord disease administered to dogs with spinal cord disease, which is a formulation containing a compound of formula (I) as an active ingredient [where R represents hydrogen or a pharmacologically permissible cation].